“Virologic Response Following a Switch to Dolutegravir-based Regimen in People Living with HIV/AIDS at a Tertiary Care Center in Nepal”, Kathmandu Univ. Med. J., vol. 20, no. 4, pp. 438–442, Dec. 2022, doi: 10.3126/kumj.v20i4.54081.